Direxion Daily S&P Biotech Bull 3X ETF
LABU
49 hedge funds and large institutions have $50.9M invested in Direxion Daily S&P Biotech Bull 3X ETF in 2022 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 12 increasing their positions, 8 reducing their positions, and 15 closing their positions.
153% more call options, than puts
Call options by funds: $45.3M | Put options by funds: $17.9M
50% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 8
20% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 15
17% more capital invested
Capital invested by funds: $43.4M → $50.9M (+$7.44M)
4% more funds holding
Funds holding: 47 → 49 (+2)
0.07% more ownership
Funds ownership: 0.16% → 0.23% (+0.07%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$11M |
| 2 |
JF
Jump Financial
Chicago,
Illinois
|
+$8.28M |
| 3 |
HF
HRT Financial
New York
|
+$6.13M |
| 4 |
Jane Street
New York
|
+$4.96M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$3.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Simplex Trading
Chicago,
Illinois
|
-$7.38M |
| 2 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
-$6.01M |
| 3 |
SW
SVB Wealth
Boston,
Massachusetts
|
-$2.17M |
| 4 |
AIP
Ahrens Investment Partners
Lafayette,
Louisiana
|
-$2.03M |
| 5 |
Belvedere Trading
Chicago,
Illinois
|
-$687K |
LABU Hedge Fund Activity: Q4 2022 in Review
49 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily S&P Biotech Bull 3X ETF (LABU) for Q4 2022, worth a combined $50.9M — up 17% from $43.4M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new LABU positions and 15 closed out — a net gain of 3 holders — while 12 added to existing stakes and 8 trimmed.
The largest buyer was Citadel Advisors, adding an estimated $11M. The largest seller was Simplex Trading, cutting an estimated $7.38M.
- 49 institutional investors held Direxion Daily S&P Biotech Bull 3X ETF (LABU) as of Q4 2022, up from 47 in Q3 2022.
- Funds reported $50.9M of Direxion Daily S&P Biotech Bull 3X ETF stock for Q4 2022, up 17% quarter-over-quarter.
- 18 funds opened new Direxion Daily S&P Biotech Bull 3X ETF positions in Q4 2022 and 15 closed out, a net change of +3 holders.
- The largest Direxion Daily S&P Biotech Bull 3X ETF buyer in Q4 2022 was Citadel Advisors, an estimated $11M added.
- The largest Direxion Daily S&P Biotech Bull 3X ETF seller in Q4 2022 was Simplex Trading, an estimated $7.38M sold.
Based on aggregated 13F filings for Q4 2022.